Abstract
Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....
| Original language | English (US) |
|---|---|
| Title of host publication | xPharm |
| Subtitle of host publication | The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-5 |
| Number of pages | 5 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - Jan 1 2007 |
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Fingerprint Dive into the research topics of 'Myasthenia gravis'. Together they form a unique fingerprint.
Cite this
Kincaid, A. (2007). Myasthenia gravis. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-5). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.60686-5